A number of factors such as the early emergence of the dhfr triple mutant genotype in Africa [78], pervasive drug pressure from the distribution of pyrimethamine salts for malaria prophylaxis in various parts of the world [86], and human migration patterns [87], may explain the greater distribution of this genotype throughout the continent. This evidence concerns the gene DHFR and malaria.